Company Announcements

Company Announcements

Jun 17, 2019
Professor Abraham Zangen, Ph.D. Appointed as a Director JERUSALEM, Israel and HACKENSACK, N.J., June 17, 2019 (GLOBE NEWSWIRE) -- Brainsway Ltd. (NASDAQ & TASE: BWAY) (Brainsway), a commercial stage medical device company focused on the development and sale of non-invasive neuromodulation products
Apr 22, 2019
JERUSALEM, April 22, 2019 (GLOBE NEWSWIRE) -- Brainsway Ltd. (NASDAQ: BWAY and TASE: BRIN) (“Brainsway”) today announced that it has closed its initial public offering of 2,500,000 American Depositary Shares (“ADSs”), each representing two ordinary shares of Brainsway, at a public offering price of